These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 35941696)

  • 1. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
    Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
    Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe Diabetes.
    Li L; Hui H; Jia X; Zhang J; Liu Y; Xu Q; Zhu D
    Sci Rep; 2016 Dec; 6():37894. PubMed ID: 27905403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study.
    Lu J; Shen SM; Ling Q; Wang B; Li LR; Zhang W; Qu DD; Bi Y; Zhu DL
    Stem Cell Res Ther; 2021 Jun; 12(1):340. PubMed ID: 34112266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Graft-versus-Host-Disease in NOD.Cg-Prkdc
    Hansen M; Stahl L; Heider A; Hilger N; Sack U; Kirschner A; Cross M; Fricke S
    Transplant Cell Ther; 2021 Aug; 27(8):658.e1-658.e10. PubMed ID: 33964513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic expression of insulin in a type 1 diabetic rat model by injection of manipulated mesenchymal stem cells with an insulin construct driven by a glucose-sensitive promoter in the port vein.
    Mohammad Dezashibi H; Farzad-Mohajeri S; Bandehpour M; Shabani A; Kazemi B
    Cell Biochem Funct; 2023 Dec; 41(8):1412-1421. PubMed ID: 37877623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes.
    Xiao N; Zhao X; Luo P; Guo J; Zhao Q; Lu G; Cheng L
    Cytotherapy; 2013 Nov; 15(11):1374-84. PubMed ID: 24094489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
    Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
    Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model.
    Grégoire C; Ritacco C; Hannon M; Seidel L; Delens L; Belle L; Dubois S; Vériter S; Lechanteur C; Briquet A; Servais S; Ehx G; Beguin Y; Baron F
    Front Immunol; 2019; 10():619. PubMed ID: 31001253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice.
    Yin Y; Hao H; Cheng Y; Gao J; Liu J; Xie Z; Zhang Q; Zang L; Han W; Mu Y
    Int Immunopharmacol; 2018 Jul; 60():235-245. PubMed ID: 29778021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Effects of Insulin-Producing Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Type 1 Diabetes Mouse Model.
    Park YM; Yang CM; Cho HY
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrin producing syngeneic mesenchymal stem cells protect non-obese diabetic mice from type 1 diabetes.
    Gaudreau MC; Gudi RR; Li G; Johnson BM; Vasu C
    Autoimmunity; 2022 Mar; 55(2):95-108. PubMed ID: 34882054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
    Sharma A; Rani R
    Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.
    Ma Y; Wang L; Yang S; Liu D; Zeng Y; Lin L; Qiu L; Lu J; Chang J; Li Z
    Stem Cell Res Ther; 2021 Jul; 12(1):385. PubMed ID: 34233739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord-derived mesenchymal stem cells alleviate insulin resistance in diet-induced obese mice via an interaction with splenocytes.
    Xue J; Gao J; Gu Y; Wang A; Yu S; Li B; Yin Y; Wang J; Su W; Zhang H; Ren W; Gu W; Lv Z; Mu Y; Cheng Y
    Stem Cell Res Ther; 2022 Mar; 13(1):109. PubMed ID: 35313972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic control by umbilical cord-derived mesenchymal stem cells promotes effects of fasting-mimicking diet on type 2 diabetic mice.
    Zhao N; Gao YF; Bao L; Lei J; An HX; Pu FX; Cheng RP; Chen J; Ni H; Sui BD; Ji FP; Hu CH
    Stem Cell Res Ther; 2021 Jul; 12(1):395. PubMed ID: 34256832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells.
    Wu LF; Wang NN; Liu YS; Wei X
    Tissue Eng Part A; 2009 Oct; 15(10):2865-73. PubMed ID: 19257811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of repeated intravenous infusions of umbilical cord-derived versus bone marrow-derived mesenchymal stem cells on angiogenesis in a pregnant experimentally induced deep venous thrombosis rat model.
    Cheng X; Wang W; Du R; Zhang M; Xie Y; Sun W; Ji J; Sun B; Zhang Y
    In Vitro Cell Dev Biol Anim; 2022 Dec; 58(10):957-969. PubMed ID: 36469244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
    Chen MY; Lie PC; Li ZL; Wei X
    Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.